Literature DB >> 29667007

Failure in diagnosis and under-treatment of osteoporosis in elderly patients with fragility fractures.

Sofia Bougioukli1, Panagoula Κollia2, Theodora Koromila2, Sokratis Varitimidis1, Michael Hantes1, Theofilos Karachalios1, Κonstantinos Ν Malizos1, Zoe H Dailiana3.   

Abstract

We evaluated whether osteoporosis is adequately managed and treated in patients suffering from fragility fractures. Factors that influenced osteoporosis diagnosis and treatment rates were also assessed. To this end, patients with the principal diagnosis of low-energy hip, vertebral, or distal radius fractures were recruited for the study. Collected data included risk factors for osteoporosis, history of previous fractures, known history of osteoporosis, and osteoporosis treatment at the time of admission. The patients' prefracture risk profile was also assessed to determine whether osteoporosis could have been identified prior to the index fracture. We identified 308 patients with fragility fractures, including 214 hip, 41 vertebral, and 53 distal radius fractures. Overall, 238 patients (77.3%) had at least one risk factor for osteoporosis. Eighty-eight patients (28.6%) had sustained ≥ 1 prior fragility fractures in the past. However, only 79 patients (25.6%) were aware that they had osteoporosis and even fewer (66 patients, 21.4%) had been receiving osteoporosis treatment preceding the current admission. Anti-osteoporotic agents were more commonly prescribed in patients 66-75 years old (p = 0.008), with a family history of osteoporosis (p = 0.009) or history of a prior fragility fracture (p = 0.012). The treatment rate was higher in women than men (p = 0.026) and in patients with vertebral or multiple prior fractures compared to patients with prior hip fractures. The current study provides evidence that individuals who experience fragility fractures are not adequately managed for osteoporosis. Only few of the historically known risk factors for osteoporosis were adequately recognized and associated with osteoporosis evaluation and treatment.

Entities:  

Keywords:  Anti-osteoporotic treatment; Fragility fracture; Osteoporosis; Osteoporosis risk assessment

Mesh:

Substances:

Year:  2018        PMID: 29667007     DOI: 10.1007/s00774-018-0923-2

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  8 in total

1.  Editorial: Secondary Fracture Prevention-What's Your System?

Authors:  Seth S Leopold
Journal:  Clin Orthop Relat Res       Date:  2020-04-23       Impact factor: 4.176

Review 2.  Cardiovascular Safety and Effectiveness of Bisphosphonates: From Intervention Trials to Real-Life Data.

Authors:  Chiara Delli Poggi; Maria Fusaro; Maria Cristina Mereu; Maria Luisa Brandi; Luisella Cianferotti
Journal:  Nutrients       Date:  2022-06-07       Impact factor: 6.706

3.  Prevalence and treatment of fragility fractures in Spanish primary care: PREFRAOS study.

Authors:  Daniel Martínez-Laguna; Cristina Carbonell; José-Carlos Bastida; Milagros González; Rafael M Micó-Pérez; Francisco Vargas; Mónica Balcells-Oliver; Laura Canals
Journal:  Arch Osteoporos       Date:  2022-07-15       Impact factor: 2.879

4.  Editorial: Secondary Fracture Prevention-What's Your System?

Authors:  Seth S Leopold
Journal:  Clin Orthop Relat Res       Date:  2020-08       Impact factor: 4.755

5.  Higher Mortality in Men Compared with Women following Distal Radius Fracture in Population Aged 50 Years or Above: Are Common Distal Radius Fracture Classifications Useful in Predicting Mortality?

Authors:  Jakub Marchewka; Jacek Głodzik; Wojciech Marchewka; Edward Golec
Journal:  Biomed Res Int       Date:  2019-01-23       Impact factor: 3.411

Review 6.  Osteoporosis case ascertainment strategies in European and Asian countries: a comparative review.

Authors:  A M Burden; Y Tanaka; L Xu; Y-C Ha; E McCloskey; S R Cummings; C C Glüer
Journal:  Osteoporos Int       Date:  2020-12-10       Impact factor: 4.507

7.  Overview of fracture liaison services in the UK and Europe: standards, model of care, funding, and challenges.

Authors:  Timothy J S Chesser; Muhammad Kassim Javaid; Zaineb Mohsin; Carlotta Pari; Alberto Belluati; Achille Contini; Vincenzo Caiaffa; Francisco Chana-Rodríguez; Jesus Gómez-Vallejo; Coral Sánchez-Pérez; Zoe H Dailiana; Nikolaos Stefanou; Theodoros Tosounidis; Michaël Laurent; Guy Putzeys; Martijn Poeze; Kees Jan Ponsen
Journal:  OTA Int       Date:  2022-06-09

8.  H. Pylori is related to osteoporosis but only in premenopausal female: a cross-sectional study.

Authors:  Jing-Wei Wang; Feng-Xiao Dong; Hui Su; Licun Zhu; Sujun Shao; Hong Liu
Journal:  BMC Musculoskelet Disord       Date:  2020-08-18       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.